Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Calvert

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
The Hospital|May 30, 2018
St. Bartholomew's HospitalSamuel Gee, Dyce Duckworth, T Lauder Brunton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROREmily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
JAMA|May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics GuidelinesSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Nature Medicine|February 29, 2024
Recommendations to address respondent burden associated with patient-reported outcome assessmentOlalekan Lee Aiyegbusi, Samantha Cruz Rivera, Jessica Roydhouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003N W Clarke, A Ali, F C Ingleby, et al.
The Lancet. Oncology|November 27, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trialsCecilie D Amdal, Ragnhild S Falk, Ahu Alanya, et al.
Health Technology Assessment (Winchester, England)|August 9, 2019
Three wound-dressing strategies to reduce surgical site infection after abdominal surgery: the Bluebelle feasibility study and pilot RCTBarnaby C Reeves, Leila Rooshenas, Rhiannon C Macefield, et al.
Persoonia|August 30, 2021
Fungal Planet description sheets: 1112-1181P W Crous, D A Cowan, G Maggs-Kölling, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
The Hospital|May 30, 2018
St. Bartholomew's HospitalSamuel Gee, Dyce Duckworth, T Lauder Brunton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROREmily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck, et al.
JAMA|May 17, 2022
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical Research: The PRO Ethics GuidelinesSamantha Cruz Rivera, Olalekan Lee Aiyegbusi, Jonathan Ives, et al.
Nature Medicine|February 29, 2024
Recommendations to address respondent burden associated with patient-reported outcome assessmentOlalekan Lee Aiyegbusi, Samantha Cruz Rivera, Jessica Roydhouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003N W Clarke, A Ali, F C Ingleby, et al.
The Lancet. Oncology|November 27, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trialsCecilie D Amdal, Ragnhild S Falk, Ahu Alanya, et al.
Health Technology Assessment (Winchester, England)|August 9, 2019
Three wound-dressing strategies to reduce surgical site infection after abdominal surgery: the Bluebelle feasibility study and pilot RCTBarnaby C Reeves, Leila Rooshenas, Rhiannon C Macefield, et al.
Persoonia|August 30, 2021
Fungal Planet description sheets: 1112-1181P W Crous, D A Cowan, G Maggs-Kölling, et al.
Pageof 23